PRTN3 and osteoporosis: A study of Bruno et al. [14] has demonstrated an increased prevalence of osteopenia and osteoporosis in ACPA-positive vs. ACPA-negative patients in a cohort of 71 early RA patients that underwent femoral or lumbar spine DEXA.